Related references
Note: Only part of the references are listed.Natural killer-cell differentiation by myeloid progenitors
Bartosz Grzywacz et al.
BLOOD (2011)
NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions
Bree Foley et al.
BLOOD (2011)
Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new
James M. Coghill et al.
BLOOD (2011)
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
Don M. Benson et al.
BLOOD (2011)
Efficacy of Large Doses of IL-2-Activated Human Leukocyte Antigen Haploidentical Peripheral Blood Stem Cells on Refractory Metastatic Renal Cell Carcinoma
Shui Cao et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2011)
Interleukin 15 as a promising candidate for tumor immunotherapy
Marek Jakobisiak et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Ex vivo expansion of natural killer cells: a question of function
Tolga Sutlu et al.
CYTOTHERAPY (2011)
CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation
Vivien Beziat et al.
JOURNAL OF IMMUNOLOGY (2011)
Different NK Cell Developmental Events Require Different Levels of IL-15 Trans-Presentation
Gilbert Aaron Lee et al.
JOURNAL OF IMMUNOLOGY (2011)
Possibility of Adoptive Immunotherapy With Peripheral Blood-derived CD3-CD56+ and CD3+CD56+ Cells for Inducing Antihepatocellular Carcinoma and Antihepatitis C Virus Activity
Marlen Doskali et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
Jan Spanholtz et al.
PLOS ONE (2011)
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells
Paola Vacca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Bjorkstrom et al.
BLOOD (2010)
Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
Uwe Siegler et al.
CYTOTHERAPY (2010)
Ex-vivo expansion of NK cells: What is the priority - high yield or high purity?
Maria Berg et al.
CYTOTHERAPY (2010)
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
Tolga Sutlu et al.
CYTOTHERAPY (2010)
Natural killer cells in human autoimmune diseases
Nicolas Schleinitz et al.
IMMUNOLOGY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
Jan Spanholtz et al.
PLOS ONE (2010)
The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor Cells
Rose C. Beck et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
Petter S. Woll et al.
BLOOD (2009)
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagne et al.
BLOOD (2009)
Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage-cells into pseudomature lytic NK cells
Giuseppina Bonanno et al.
BMC IMMUNOLOGY (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
L. Barkholt et al.
IMMUNOTHERAPY (2009)
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Nicholas D. Huntington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo
Shintaro Kamizono et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Marina Cella et al.
NATURE (2009)
The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development
Duncan M. Gascoyne et al.
NATURE IMMUNOLOGY (2009)
Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
Evren Alici et al.
BLOOD (2008)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
Generation of functional natural killer and dendritic cells in a human stromal-based serum-free culture system designed for cord blood expansion
Ana M. Frias et al.
EXPERIMENTAL HEMATOLOGY (2008)
Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15
Valarie McCullar et al.
EXPERIMENTAL HEMATOLOGY (2008)
Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells
A. Arina et al.
GENE THERAPY (2008)
IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation
Erwan Mortier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Adoptive transfer of gene-modified primary NK cells can specifically inhibit tumor progression in vivo
Hollie J. Pegram et al.
JOURNAL OF IMMUNOLOGY (2008)
An unusual CD56bright CD16low NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation
Nicolas Dulphy et al.
JOURNAL OF IMMUNOLOGY (2008)
Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34+ Progenitors Promoted by Membrane-Bound IL-15
Massimo Giuliani et al.
PLOS ONE (2008)
Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells
I-Ting Kao et al.
STEM CELLS AND DEVELOPMENT (2007)
Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model
Evren Alici et al.
EXPERIMENTAL HEMATOLOGY (2007)
Antitumor effect of large doses IL-2-activated HLA haploidentical peripheral blood stem cells on refractory metastatic solid tumor treatment
Xiu-Bao Ren et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)
Differences between human embryonic stem cell lines
C. Allegrucci et al.
HUMAN REPRODUCTION UPDATE (2007)
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells
Bartosz Grzywacz et al.
BLOOD (2006)
Human natural killer cell development
Aharon G. Freud et al.
IMMUNOLOGICAL REVIEWS (2006)
A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127
Christian A. J. Vosshenrich et al.
NATURE IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Human NK cell education by inhibitory receptors for MHC class I
Nicolas Anfossi et al.
IMMUNITY (2006)
Effect of IL-21 on NK cells derived from different umbilical cord blood populations
SA Perez et al.
INTERNATIONAL IMMUNOLOGY (2006)
Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity
PS Woll et al.
JOURNAL OF IMMUNOLOGY (2005)
Licensing of natural killer cells by host major histocompatibility complex class I molecules
S Kim et al.
NATURE (2005)
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
C Imai et al.
BLOOD (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
CD34+cells cultured in stem cell factor and interleukin-2 generate CD56+cells with antiproliferative effects on tumor cell lines
G Sconocchia et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells
AG Freud et al.
IMMUNITY (2005)
Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood
R Haddad et al.
BLOOD (2004)
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
JR Passweg et al.
LEUKEMIA (2004)
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation
U Koehl et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells
CP Kalberer et al.
BLOOD (2003)
What does it take to make a natural killer?
F Colucci et al.
NATURE REVIEWS IMMUNOLOGY (2003)
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells
MA Cooper et al.
BLOOD (2002)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Natural selection of tumor variants in the generation of tumor escape phenotypes
HT Khong et al.
NATURE IMMUNOLOGY (2002)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
I Petit et al.
NATURE IMMUNOLOGY (2002)
Early expression of triggering receptors and regulatory role of 2134 in human natural killer cell precursors undergoing in vitro differentiation
S Sivori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Stromal cell lines from mouse aorta-gonads-mesonephros subregions are potent supporters of hematopoietic stem cell activity
RAJ Oostendorp et al.
BLOOD (2002)
Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission
GF Torelli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
NK cells, MHC class I molecules and the missing self
K Karre
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
JS Miller et al.
BLOOD (2001)
Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset
MA Cooper et al.
BLOOD (2001)
In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34+ cord blood cells
L Kobari et al.
EXPERIMENTAL HEMATOLOGY (2000)
Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer
M deMagalhaes-Silverman et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Share Paper
